SCHEDULE 13G: John Hathaway and SkinJect Partners Disclose 6.8% Passive Stake in Medicus Pharma Ltd.
Beneficial Ownership Disclosure
John Hathaway and SkinJect Partners LLC have disclosed a passive beneficial ownership of 6.8% of Medicus Pharma Ltd.'s common shares, totaling 800,952 shares, as of December 31, 2024.
Summary
- John Hathaway and SkinJect Partners LLC have filed a Schedule 13G with the SEC, reporting their beneficial ownership in Medicus Pharma Ltd.
- The reporting persons collectively own 800,952 common shares of Medicus Pharma Ltd.
- This ownership stake represents 6.8% of the company's total outstanding common shares.
- The percentage is calculated based on 11,816,721 common shares reported by Medicus Pharma Ltd. as outstanding as of November 22, 2024.
- SkinJect Partners LLC directly holds the shares, and John Hathaway, who controls SkinJect Partners LLC, is deemed a beneficial owner of these securities.
Sentiment
Score: 5
Explanation: The document is a routine beneficial ownership disclosure (Schedule 13G) and does not contain information that would inherently lead to a positive or negative sentiment. It is a factual report of ownership.
Stakeholder Impact
- Shareholders: Provides transparency regarding significant ownership stakes, which can offer insights into the company's ownership structure and potential long-term investor confidence.
Key Dates
| Date | Description |
|---|---|
| November 22, 2024 | Date as of which Medicus Pharma Ltd. reported 11,816,721 common shares outstanding, used for percentage calculation. |
| December 31, 2024 | Date of the event which required the filing of this statement (end of year ownership). |
| February 10, 2025 | Date the Schedule 13G was signed and filed with the SEC. |
Keywords
Medicus Pharma Ltd., John Hathaway, SkinJect Partners LLC, Schedule 13G, beneficial ownership, common shares, passive investment, SEC filing, pharmaceutical, healthcare
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.